stearoylethanolamide has been researched along with Acute Confusional Senile Dementia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gula, N; Horid'ko, T; Komisarenko, S; Kosiakova, H; Koval, L; Lykhmus, O; Lytovchenko, D; Skok, M; Uspenska, K; Voytenko, L | 1 |
1 other study(ies) available for stearoylethanolamide and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
N-Stearoylethanolamine protects the brain and improves memory of mice treated with lipopolysaccharide or immunized with the extracellular domain of α7 nicotinic acetylcholine receptor.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Alzheimer Disease; Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents; Apoptosis; Brain; Cytochromes c; Ethanolamines; Female; Humans; Immunization; Lipopolysaccharides; Memory; Mice; Mice, Inbred C57BL; Mitochondria; Neurogenic Inflammation; Neuroprotection; Peptide Fragments; Protein Domains; Stearic Acids | 2017 |